Back
Codexis 10K Form
Buy
58
CDXS
Codexis
Last Price:
3.61
Seasonality Move:
-3.3%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-03 | 10Q | CDXS/Codexis Quarterly |
| 2023-08-03 | 10Q | CDXS/Codexis Quarterly |
| 2023-05-04 | 10Q | CDXS/Codexis Quarterly |
| 2022-11-04 | 10Q | CDXS/Codexis Quarterly |
| 2022-08-05 | 10Q | CDXS/Codexis Quarterly |
| 2022-05-09 | 10Q | CDXS/Codexis Quarterly |
Receive CDXS News And Ratings
See the #1 stock for the next 7 days that we like better than CDXS
CDXS Financial Statistics
Sales & Book Value
| Annual Sales: | $70.14M |
|---|---|
| Cash Flow: | $-8.92M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.12 |
| Price / Book: | 3.36 |
Profitability
| EPS (TTM): | -0.93000 |
|---|---|
| Net Income (TTM): | $-65.13M |
| Gross Margin: | $57.33M |
| Return on Equity: | -64.16% |
| Return on Assets: | -37.63% |
Codexis Earnings Forecast
Key Codexis Financial Ratios
- The Gross Profit Margin over the past 18 years for CDXS is 81.74%.
- The Selling, General & Administrative Expenses for CDXS have been equal to 75.92% of Gross Profit Margin.
- The Research & Development expenses have been 83.95% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of CDXS is -108.69% of Total Revenues.
- Per Share Earnings over the last 18 years have been positive in 6 years.
Codexis Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | CDXS |
| CUSIP: | 192005 |
| Website: | codexis.com |
Debt
| Debt-to-Equity Ratio: | 0.35 |
|---|---|
| Current Ratio: | 3.71 |
| Quick Ratio: | 3.43 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |